SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION
Ask a doctor about a prescription for SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION
How to use SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION
Introduction
Prospectus: information for the user
Sorbisterit
Powder for oral/rectal suspension
Calcium polystyrene sulfonate
Read the entire prospectus carefully before starting to use this medication, as it contains important information for you.
- Keep this prospectus, as you may need to read it again.
- If you have any doubts, consult your doctor or pharmacist.
- This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
- If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this prospectus. See section 4.
Contents of the prospectus:
- What Sorbisterit is and what it is used for
- What you need to know before starting to use Sorbisterit
- How to use Sorbisterit
- Possible side effects
- Storage of Sorbisterit
- Package contents and additional information
1. What Sorbisterit is and what it is used for
Sorbisterit is used in the treatment of hyperkalemia (high potassium levels in the blood), in patients with kidney problems and in patients undergoing dialysis (removal of waste products from the blood). Sorbisterit is a cation exchange resin (an insoluble structure that releases certain ions and exchanges them for others) that exchanges potassium for calcium in the intestine. As a result, it reduces the intake of potassium into the blood.
2. What you need to know before starting to use Sorbisterit
Do not use Sorbisterit
- If your blood contains too little potassium, manifested bysevere muscle cramps or weakness and muscle fatigue
- If your blood contains too much calcium
- If you are allergic to resins containing calcium polystyrene sulfonate or any of the other componentsof this medication (listed in section 6).
- If you have constipation or complete intestinal obstruction
- If you are taking sorbitol (a laxative)
- In newborns by mouth
- In newborns with constipation
Warnings and precautions
Consult your doctor or pharmacist before starting to use Sorbisterit
- If you are going to use it orally, you must be seated to prevent inhalation of the liquid.
- If you have constipation, you must inform your doctor before using this medication.
Every day, your blood electrolyte levels should be checked.
Consult your doctor if any of the above points apply to you or have applied in the past.
Children
Special caution is necessary when using in children and newborns, as an overdose or incorrect dilution can cause the resin to have a too strong effect. Special caution is required in individuals with low body weight, especially in newborns, due to the risk of gastrointestinal bleeding and tissue death in the colon (necrosis).
Other medications and Sorbisterit
Tell your doctorif you are using, have recently used, or may need to use any other medication.
Concomitant administrationwith other orally administered medicationsshould be avoided. Sorbisterit should be taken at least three hours before or three hours after taking other oral medications. For patients with gastroparesis, a six-hour separation should be considered.
You should consult your doctor especially if you are using:
- Sorbitolshould not be used as a laxative, as there is a risk of colon damage (necrosis)
- Potassium-containing medications
- Medications for heartburn or laxatives, such as magnesium hydroxide, aluminum hydroxide, or calcium carbonate
- Medications that increase heart efficiency, such as digoxin (cardiac glycosides), as their action may be increased
- Lithium:an antidepressant, as its intake may be reduced by Sorbisterit.
- L-thyroxine:Sorbisterit reduces the intake and, consequently, the effect of this thyroid medication.
- Medications that interact with calcium:
- Ciprofloxacinoral, an antibiotic whose effect is reduced by Sorbisterit
- Tetracyclineoral, an antibiotic whose effect is reduced by Sorbisterit
- Medications that eliminate fluids from tissues, such as hydrochlorothiazide (thiazide diuretics) or furosemide or torasemide (loop diuretics)
- Certain types of medications that affect nerve cells or nerve fibers(anticholinergics) as there is an increased risk of Sorbisterit side effects in the stomach.
Using Sorbisterit with food and beverages
Sorbisterit should not be taken with fruit juices (e.g., pineapple, grapefruit, orange, tomato, or grape juice) rich in potassium, as this may negatively affect the action of Sorbisterit.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not use Sorbisterit during pregnancy or breastfeeding, unless your doctor considers it essential.
Driving and using machines
There are no known effects on the ability to drive or use machines.
Sorbisterit contains sucrose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
3. How to use Sorbisterit
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
The duration of treatment depends on daily measurements of blood potassium levels.
The recommended dose is:
Oral use
- Adults and elderly:
1 measuring spoon (20 g of powder) 1-3 times a day, suspended by shaking in about 150 ml of liquid.
- Children:
0.5 - 1 g of powder per kilogram of body weight per day, suspended by shaking in about 150 ml of liquid. This preparation is administered in at least three divided doses over a 24-hour period.
Possible liquids are water, tea, or soft drinks. Sorbisterit should be administered with the main meals and the upper body in an upright position.
Concomitant administrationwith other orally administered medicationsshould be avoided (see section 2).
Rectal use
- Adults and elderly:
After using an enema, 2 measuring spoons of Sorbisterit (40 g) are dispersed in 150 ml of 5% glucose solution and administered rectally, 1-3 times a day.
Retention time: 6 hours
- Children and newborns:
Rectal administration is performed if Sorbisterit cannot be swallowed. 0.5 - 1 g of powder per kilogram of body weight per day, dispersed in 150 ml of 5% glucose solution, and administered in at least three divided doses over a 24-hour period. Six hours after rectal administration, the colon should be irrigated to remove the resin.
If you notice that the effect of Sorbisterit is too strong or too weak, consult your doctor or pharmacist.
If you use more Sorbisterit than you should
If you have used too much Sorbisterit, inform your doctor or pharmacist immediately. In general, an overdose of Sorbisterit can cause a reduced potassium level in the blood (hypokalemia) with symptoms of cramps, leg discomfort while sitting, extreme body weakness, and occasionally paralysis. There may be an abnormal heartbeat. Other side effects of an overdose may include an elevated calcium level in the blood (hypercalcemia) with symptoms such as fatigue, muscle weakness, frequent urination, constipation, abnormal heartbeat, kidney failure, or coma. Additionally, an overdose can cause constipation, complete intestinal obstruction, and fluid accumulation.
If you forget to use Sorbisterit
Consult your doctor or pharmacist
Do not take a double dose to make up for forgotten doses
If you stop treatment with Sorbisterit
This may cause an increase in blood potassium levels.
If you have any other questions about using this medication, ask your doctor or pharmacist.
4. Possible side effects
Like all medications, this medication can cause side effects, although not everyone will experience them.
Tell your doctor or nurse immediately if you notice any of the following serious side effects:
- Severe stomach pain, rectal pain
- Abdominal distension, severe constipation
- Severe nausea and vomiting
- Black, bloody, or tarry stools, coughing up blood or vomiting that looks like "coffee grounds"
The assessment of side effects was based on the following frequency of data:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people, including isolated reports.
Frequency not known: cannot be estimated from the available data
Common:
- too much calcium in the blood
- too little potassium in the blood, manifested in severe form by muscle cramps or weakness and muscle fatigue
- too little magnesium in the blood
- nausea
- vomiting
Uncommon:
- constipation
- diarrhea
- stomach ulcers
- colon damage, which can cause intestinal perforation (sometimes with fatal outcome)
- loss of appetite
- intestinal obstruction
Rare:
- complete intestinal obstruction, resulting in severe cases of
- accumulation of the resin in the intestine
- "thickening" of the stool after rectal use in children
- formation of plugs after oral use in newborns
- anal bleeding has been observed after rectal use in premature and low-birth-weight newborns.
Very rare:
- acute inflammation of the respiratory tract, manifested by coughing and vomiting and sputum, and/or a particular type of pneumonia caused by inhalation of this medication.
Frequency not known:
- insufficient blood supply to the stomach or intestine
- severe stomach pain, rectal pain
- black, bloody, or tarry stools, coughing up blood or vomiting that looks like "coffee grounds"
When used orally, you may have difficulty swallowing the large amount of dissolved powder.
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this prospectus. You can also report them directly through the Spanish Medication Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
5. Storage of Sorbisterit
Keep this medication out of the sight and reach of children.
Keep the container tightly closed to protect it from moisture.
Do not use this medication after the expiration date shown on the container after EXP. The expiration date is the last day of the month indicated.
Expiration after first opening: 3 months.
Medications should not be disposed of through wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
6. Package contents and additional information
Sorbisterit composition:
- The active ingredient is calcium polystyrene sulfonate. 1 g of Sorbisterit contains 759 to 949 mg of calcium polystyrene sulfonate. 20 g of Sorbisterit contain 15.18 to 18.98 g of calcium polystyrene sulfonate
- The other ingredients are sugar and citric acid.
Appearance of the product and package contents
Sorbisterit is a fine, cream to light brown powder and is available in a 500 g bottle with a measuring spoon.
Marketing authorization holder and manufacturer
Marketing authorization holder
Fresenius Medical Care Nephrologica Deutschland GmbH
Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H., Germany
Manufacturer
Fresenius Medical Care Deutschland GmbH
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H., Germany
Local representative
Vifor Fresenius Medical Care Renal Pharma España S.L.
Avenida Diagonal 613
Barcelona 08028 - Spain
Date of the last revision of this prospectus: 08/2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
How much does SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION cost in Spain ( 2025)?
The average price of SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION in December, 2025 is around 35.31 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
- Country of registration
- Average pharmacy price35.31 EUR
- Availability in pharmaciesSupply issue reported
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSIONDosage form: ORAL SOLUTION/SUSPENSION, 99.75 G OF CALCIUM POLISTYRENE SULFONATE PER 100Active substance: polystyrene sulfonateManufacturer: Laboratorios Rubio S.A.Prescription requiredDosage form: ORAL SOLUTION/SUSPENSION, 99.75G/100GActive substance: polystyrene sulfonateManufacturer: Laboratorios Rubio S.A.Prescription requiredDosage form: TABLET, 800 mgActive substance: sevelamerManufacturer: Sanofi Winthrop IndustriePrescription required
Alternatives to SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION in Poland
Online doctors for SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SORBISTERIT POWDER FOR ORAL/RECTAL SUSPENSION – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
